SCHEMBL1173113

SCHEMBL1173113

CCCCCCCC(=O)OCC(C)OCC(C)O

nearest known ligand 0.78

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.78
LMNA P02545 4/20 0.59
KDM4E B2RXH2 1/20 0.59
DUSP3 P51452 1/20 0.59
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
ALDH1A1 P00352 1/20 0.57
DGKA P23743 2/20 0.53
PRKCA P17252 3/20 0.53
PRKCE Q02156 1/20 0.53
PRKCQ Q04759 1/20 0.53
PRKCD Q05655 1/20 0.53
LPAR6 P43657 1/20 0.52
LPAR1 Q92633 1/20 0.52
LPAR4 Q99677 1/20 0.52
LPAR5 Q9H1C0 1/20 0.52
LPAR2 Q9HBW0 1/20 0.52
LPAR3 Q9UBY5 1/20 0.52
ENPP2 Q13822 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895593 1.00 MAPT (0.78) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL8950262 1.00 MAPT (0.78) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL10784276 1.00 MAPT (0.78) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL17668918 1.00 MAPT (0.78) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL323988 1.00 MAPT (0.78) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL15665486 1.00 MAPT (0.78) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL15665017 1.00 MAPT (0.78) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL630648 0.98 MAPT (0.76) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL10674380 0.98 MAPT (0.76) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL10673541 0.98 MAPT (0.76) MAPTLMNAKDM4EDUSP3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250041179-A1 ANTIMICROBIAL COMBINATIONS SYMRISE AG (DE) 2025-02-06 US claimed
US-20250000766-A1 ANTIMICROBIAL ESTERS FOR SKIN AND SCALP CARE SYMRISE AG (DE) 2025-01-02 US claimed
EP-4392002-A1 ANTIMICROBIAL ESTERS FOR SKIN AND SCALP CARE Symrise AG (DE) 2024-07-03 EP claimed
EP-4391809-A2 ANTIMICROBIAL COMBINATIONS Symrise AG (DE) 2024-07-03 EP claimed
CN-117858620-A Antimicrobial combinations 西姆莱斯有限公司 2024-04-09 CN claimed
WO-2023025399-A1 ANTIMICROBIAL ESTERS FOR SKIN AND SCALP CARE SYMRISE AG (DE) 2023-03-02 WO claimed
WO-2021224509-A2 ANTIMICROBIAL COMBINATIONS SYMRISE AG (DE) 2021-11-11 WO claimed
CN-102725032-A Ammonia-containing permanent agent and application of dipropylene glycol and ester compounds thereof as permanent product SHANGHAI SCHOBRUNN FINE CHEMICALS CO LTD 2012-10-10 CN claimed
EP-3795141-B1 SOLID SOLUTION COMPOSITIONS INFIRST HEALTHCARE LTD (GB) 2025-07-30 EP disclosed
US-20250041179-A1 ANTIMICROBIAL COMBINATIONS SYMRISE AG (DE) 2025-02-06 US disclosed
US-20250000766-A1 ANTIMICROBIAL ESTERS FOR SKIN AND SCALP CARE SYMRISE AG (DE) 2025-01-02 US disclosed
US-20240277613-A1 Solid Solution Compositions and Use in Chronic Inflammation INFIRST HEALTHCARE LIMITED (GB) 2024-08-22 US disclosed
EP-4391809-A2 ANTIMICROBIAL COMBINATIONS Symrise AG (DE) 2024-07-03 EP disclosed
EP-4392002-A1 ANTIMICROBIAL ESTERS FOR SKIN AND SCALP CARE Symrise AG (DE) 2024-07-03 EP disclosed
EP-1141111-A1 GEL COMPOSITIONS Penreco (US) 2001-10-10 EP disclosed
WO-2000026285-A1 GEL COMPOSITIONS PENRECO (US) 2000-05-11 WO disclosed
EP-0497896-B1 NON-PHOTOGRAPHIC METHOD FOR PATTERNING ORGANIC POLYMER FILMS DU PONT (US) 1997-03-19 EP disclosed
EP-0497896-A1 NON-PHOTOGRAPHIC METHOD FOR PATTERNING ORGANIC POLYMER FILMS. DU PONT (US) 1992-08-12 EP disclosed
US-5032216-A Non-photographic method for patterning organic polymer films E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-07-16 US disclosed
WO-1991006118-A1 NON-PHOTOGRAPHIC METHOD FOR PATTERNING ORGANIC POLYMER FILMS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250041179-A1 ANTIMICROBIAL COMBINATIONS C9, POLR1C, C1S MAPT 3303/4885LMNA 2344/4885KDM4E 3208/4885
US-20250000766-A1 ANTIMICROBIAL ESTERS FOR SKIN AND SCALP CARE CUTA, CYP51A1, ELOVL5 MAPT 2037/4885LMNA 4344/4885KDM4E 564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.